Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-006741

Director acquired 5,542 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Velleca Mark A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-06-17 Grant or award : show line 1 in the form +5,542 $2.03 $11,250 8,439 D
Loading xslF345X03/form4-06172022_010656.xml…